CH555845A - Verfahren zur herstellung von oxazolidinonen und deren verwendung. - Google Patents
Verfahren zur herstellung von oxazolidinonen und deren verwendung.Info
- Publication number
- CH555845A CH555845A CH764267A CH764267A CH555845A CH 555845 A CH555845 A CH 555845A CH 764267 A CH764267 A CH 764267A CH 764267 A CH764267 A CH 764267A CH 555845 A CH555845 A CH 555845A
- Authority
- CH
- Switzerland
- Prior art keywords
- oxazolidinone
- methyl
- compounds
- formula
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55687266A | 1966-06-13 | 1966-06-13 | |
US75537068A | 1968-08-26 | 1968-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH555845A true CH555845A (de) | 1974-11-15 |
Family
ID=27071276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH764267A CH555845A (de) | 1966-06-13 | 1967-05-30 | Verfahren zur herstellung von oxazolidinonen und deren verwendung. |
Country Status (11)
Country | Link |
---|---|
US (2) | US3455941A (da) |
BE (1) | BE699845A (da) |
CH (1) | CH555845A (da) |
DE (1) | DE1695638A1 (da) |
DK (1) | DK127066B (da) |
ES (1) | ES341733A1 (da) |
FR (1) | FR6693M (da) |
GB (1) | GB1167392A (da) |
IL (1) | IL28125A (da) |
NL (2) | NL6708113A (da) |
SE (1) | SE325576B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3856962A (en) * | 1973-07-10 | 1974-12-24 | R Alphin | Anti-inflammatory agents |
US3895021A (en) * | 1973-09-04 | 1975-07-15 | Smithkline Corp | N-heterocyclic pulvinic acid amides |
AU607735B2 (en) * | 1987-05-07 | 1991-03-14 | A.H. Robins Company, Incorporated | Novel cyclic carbamate derivatives |
US5086055A (en) * | 1990-12-24 | 1992-02-04 | A. H. Robins Company, Incorporated | Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions |
US5162322A (en) * | 1991-03-06 | 1992-11-10 | A. H. Robbins Company, Incorporated | Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones |
JPH09504272A (ja) * | 1993-09-15 | 1997-04-28 | メルク シヤープ エンド ドーム リミテツド | ドーパミンアンタゴニストとしてのイミダゾロン及びオキサゾロン誘導体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2537854A (en) * | 1949-07-08 | 1951-01-09 | Hoffmann La Roche | Tetrahydropyridines and method of manufacture |
US3085093A (en) * | 1961-09-25 | 1963-04-09 | Warner Lambert Pharmaceutical | 1, 6-bis(2, 2, 6, 6-tetramethylpiperidino)-2, 4-hexadiyne |
DE1210874B (de) * | 1961-12-14 | 1966-02-17 | Degussa | Verfahren zur Herstellung von Diarylaminoderivaten von Arylaminoalkanen |
-
0
- NL NL130094D patent/NL130094C/xx active
-
1966
- 1966-06-13 US US556872A patent/US3455941A/en not_active Expired - Lifetime
-
1967
- 1967-05-30 CH CH764267A patent/CH555845A/de not_active IP Right Cessation
- 1967-06-09 IL IL28125A patent/IL28125A/en unknown
- 1967-06-09 NL NL6708113A patent/NL6708113A/xx unknown
- 1967-06-10 DE DE19671695638 patent/DE1695638A1/de active Pending
- 1967-06-12 FR FR109984A patent/FR6693M/fr not_active Expired
- 1967-06-12 DK DK304467AA patent/DK127066B/da not_active IP Right Cessation
- 1967-06-13 SE SE08335/67A patent/SE325576B/xx unknown
- 1967-06-13 ES ES341733A patent/ES341733A1/es not_active Expired
- 1967-06-13 GB GB27291/67A patent/GB1167392A/en not_active Expired
- 1967-06-13 BE BE699845D patent/BE699845A/xx not_active IP Right Cessation
-
1968
- 1968-08-26 US US755370A patent/US3513236A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES341733A1 (es) | 1968-07-01 |
NL6708113A (da) | 1967-12-14 |
IL28125A (en) | 1972-07-26 |
BE699845A (da) | 1967-11-16 |
US3455941A (en) | 1969-07-15 |
DK127066B (da) | 1973-09-17 |
SE325576B (da) | 1970-07-06 |
NL130094C (da) | 1900-01-01 |
GB1167392A (en) | 1969-10-15 |
DE1695638A1 (de) | 1972-03-02 |
FR6693M (da) | 1969-02-10 |
US3513236A (en) | 1970-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1595915C3 (de) | Pyrrolidinderivate | |
DE69623631T2 (de) | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine als neurothophe und neuroprotektive wirkstoffe | |
DE3688827T2 (de) | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. | |
DE3001328C2 (da) | ||
DE69023928T2 (de) | DIAMINVERBINDUNGEN UND ARZNEIMITTEL GEGEN CEREBRALE STöRUNGEN DIE DIESE ENTHALTEN. | |
DE69329894T2 (de) | Arylamidderivate | |
DE3883387T2 (de) | Bis(methylendioxy)biphenyl-Verbindungen. | |
DE2065636A1 (de) | Neue tricyclische verbindungen | |
DE2807623C2 (de) | 2-Phenoxyphenyl-pyrrolidinderivate, deren Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
DE2719211C3 (de) | 1-(2-Phenylamino-äthyl)-4-(N-phenyl-N-propionylamino)-piperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
CH631164A5 (de) | Verfahren zur herstellung von neuem 1-cyclopropylmethyl-4-(3-jod-5h-dibenzo(a,d)cyclohepten-5-yliden)piperidin. | |
DE69014064T2 (de) | Benzopyranon-beta-D-thioxyloside, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung. | |
DE2006978B2 (de) | N- [H3-Trifluormethyl-phenyl)-propyl-(2)] -glycinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
DE2618999C2 (de) | 1-{[5-(4-Hydroxy-2H-1,2-benzothiazin-3-yl)-1,2.4-oxadiazol-3-yl]methyl}-äthanon-S,S-dioxide, Verfahren zu ihrer Herstellung sowie Verfahren zu ihrer Weiterverarbeitung | |
CH555845A (de) | Verfahren zur herstellung von oxazolidinonen und deren verwendung. | |
DE69119509T2 (de) | Benzhydryloxyethylpiperidyl-Derivate aliphatischer Carbonsäuren und ihre Anwendung zur Behandlung von Allergien und Asthma | |
DE3025436A1 (de) | Neue alpha -phenyl-2-pyrrolidinmethanol-derivate und ihre salze, ihr herstellungsverfahren, ihre verwendung als arzneimittel und die diese enthaltenden zusammensetzungen | |
DE2348973C3 (de) | 1 -(m-Trifluormethylphenyl)-4-propyIpiperazin-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE69110217T2 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
DE2017256A1 (de) | l-Carbamoyl-3-pheny!pyrrolidine und Verfahren zu deren Herstellung | |
DE2517020A1 (de) | Alkanolaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
CH610330A5 (en) | Process for the preparation of novel ergopeptins | |
DE2907379A1 (de) | Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
DE2428200A1 (de) | Essigsaeurederivate, verfahren zu deren herstellung und diese derivate enthaltende arzneimittel | |
DE1620746A1 (de) | Verfahren zur Herstellung von Phenothiazin-Derivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |